Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
TAG Oil prepares for flow testing of its first unconventional oil well in Egypt (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Immunoprecise Antibodies Ltd IPA

Technology Scientific & Technical Instruments
ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, and others. The majority of its revenue is derived from the United... see more

Recent & Breaking News (NDAQ:IPA)

ImmunoPrecise Antibodies And InterSystems Partner To Leverage AI In Life Sciences, Transforming Patient Care With Accelerated Discovery And Delivery Of Treatments

Accesswire 6 days ago

InterSystems and IPA's Subsidiary BioStrand Collaborate to Unveil the Innovative Integration of Vector Search with LENSai for AI-Driven Healthcare Applications

Business Wire March 28, 2024

IPA Acquires the Carterra LSA® Instrument to Enhance Antibody Discovery and Bolster Its AI Developments

Business Wire March 20, 2024

IPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024*

Business Wire March 14, 2024

ImmunoPrecise Antibodies (NASDAQ:IPA) Subsidiary BioStrand Introduces Breakthrough AI Model In Life Sciences, Harnessing LLM Stacking And HYFT Technology

Accesswire March 8, 2024

IPA's subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing LLM Stacking and HYFT Technology

Business Wire March 7, 2024

IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024 on March 14, 2024

Business Wire March 4, 2024

ImmunoPrecise Antibodies (NASDAQ:IPA) Is Changing How We Look At The Complex World Of Antibody Discovery

Accesswire February 13, 2024

ImmunoPrecise Antibodies Reports A 19.9% Revenue Increase As It Launches The Next Phase Of LENSai Portal And SaaS Platforms

Accesswire January 10, 2024

IPA Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2024*

Business Wire December 14, 2023

IPA Announces Closing of $1.265 Million Public Offering of Common Shares

Business Wire December 8, 2023

ImmunoPrecise Antibodies Welcomes Mitch Levine To Its Board Of Directors, To Announce Quarterly Results On December 14

Accesswire December 7, 2023

IPA Announces Pricing of $1.1 Million Public Offering of Common Shares

Business Wire December 6, 2023

IPA Announces Proposed Public Offering of Common Shares

Business Wire December 5, 2023

ImmunoPrecise Antibodies Ltd. Announces Key Board and Board Committee Chair Appointments and Second Quarter 2024 Earnings Release Call

Business Wire November 27, 2023

ImmunoPrecise's BioStrand(R) Unifies Diverse Data Modalities, Launches AI-Driven Platform For Enhanced Drug Discovery

Accesswire November 22, 2023

IPA's Subsidiary, BioStrand, Provides an Update on LENSai(TM)

Business Wire October 25, 2023

IPA Provides Update on Growth Strategy and Recent Share Price Movement

Business Wire October 23, 2023

Overcoming the Information Integration Dilemma: Revolutionizing The Fusion Of Complex Biological Data

Accesswire October 20, 2023

How ImmunoPrecise Antibodies Is Leveraging AI To Revolutionize Antibody Research

Accesswire October 13, 2023